Natera price to free cash flow NTRA

Market value divided by free cash flow over the last twelve months, since 2025.

Today, Oct 23, 2026: n/m; a sliver of free cash flow
Last meaningful: 367×; Jul 2026
Peer median: 32.4×

Natera's price to free cash flow is not a meaningful number today: a multiple this high rests on a sliver of free cash flow.

It was last meaningful in Jul 2026, at 367×.

Price to free cash flow over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	367×	237×	383×
2025	304×	199×	318×

Against its peers

Companies in Medical - Diagnostics & Research nearest Natera's size, closest first, today.

Company	Price to free cash flow
NTRANatera	n/m
AAgilent Technologies	38.5×
IQVIQVIA	21.1×
WATWaters	112×
IDXXIDEXX Laboratories	35.2×
ILMNIllumina	43.7×
MTDMettler-Toledo International	38.7×
DGXQuest Diagnostics	19.8×
LHLabcorp	23.1×
DHRDanaher	29.6×
MEDPMedpace	26.4×
Peer median	32.4×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Natera

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.